PAMU
NRIX icon

Pictet Asset Management (UK)’s Nurix Therapeutics NRIX Stock Holding History

Pictet Asset Management (UK)’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$18M Buy
676,887
+277,491
+69% +$8.15M 0.02% 544
2021
Q1 		$12.4M Buy
+399,396
New +$15.1M 0.01% 613

Other funds holding NRIX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Pictet Asset Management (UK)'s NRIX Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Nurix Therapeutics (NRIX) stake by 69% in Q2 2021, buying an estimated $8.15M and bringing the position to 676,887 shares worth $18M. The position accounts for 0.02% of the portfolio, ranked #544.

Pictet Asset Management (UK) first reported a position in NRIX in Q1 2021 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold NRIX as of Q2 2021.

  • Pictet Asset Management (UK) held 676,887 shares of Nurix Therapeutics worth $18M as of Q2 2021.
  • Pictet Asset Management (UK) bought 277,491 Nurix Therapeutics shares in Q2 2021, an estimated $8.15M.
  • Nurix Therapeutics made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #544 holding.
  • Pictet Asset Management (UK) first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.